Search Results for "Reminder Sample Letter Prostate Cancer"

12:31 EDT 30th May 2015 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Cancer biology: Studying a new subtype of prostate cancer

A better understanding of a common gene mutation in prostate cancer cells may lead to novel strategies for combating lethal prostate cancer

Link Found Between Breast-Cancer Genes, Prostate Cancer

A man receives a medical scan to check for prostate cancer. PHOTO: GETTY IMAGES SOURCE Study finds BRCA1 or BRCA2 mutations in prostate-cancer patients Mutations in two genes well known for increasing...

Predicting prostate cancer: Nanotechnology shows promise for more accurate prostate cancer screening and prognosis

A study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments. The prostate-specific antigen (PSA) te...

Prostate cancer: Predicting prostate biopsy results—PCA3 versus phi

Data comparing tests designed to predict the likelihood of finding significant prostate cancer on biopsy are limited. A comparison of two such tests—the Prostate Health Index (phi) and prostate canc...

Drug Combo SuppressesLate-Stage Prostate Cancer Growth

Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds....

New study findings help physicians and patients determine prostate cancer risk

(University of Utah Health Sciences) A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man's uncles and great-grandparents, among other second- and third-degree r...

Common prostate cancer treatment associated with decreased survival in older men

A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at Henry Ford Hospital.

Bone Complications Among Prostate Cancer Survivors

Long-term use of ADT may be associated with an increased risk of fracture in men with prostate cancer. Prostate Cancer and Prostatic Diseases

Matching PubMed Articles

Prevention and early detection of prostate cancer.

Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to...

Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?

For six decades, it has been a part of the conventional medical wisdom that higher levels of testosterone increase the risk of prostate cancer. This belief is mostly derived from the well-documented r...

The heritability of prostate cancer-letter.

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations.

Few previous studies of metabolic aberrations and prostate cancer risk have taken into account the fact that men with metabolic aberrations have an increased risk of death from causes other than prost...

Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group. However, it rem...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement